South & Central America Stem Cell Therapy Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)

No. of Pages: 120
Report Code: BMIRE00029077
Category: Life Sciences
South & Central America Stem Cell Therapy Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South & Central America Stem Cell Therapy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South & Central America Stem Cell Therapy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South & Central America Stem Cell Therapy Market Regional Analysis

6.2 South & Central America Stem Cell Therapy Market Revenue 2020-2028 (US$ Million)
6.3 South & Central America Stem Cell Therapy Market Forecast Analysis

7. South & Central America Stem Cell Therapy Market Analysis – by Type

7.1 Adult Stem Cell Therapy
  • 7.1.1 Overview
  • 7.1.2 Adult Stem Cell Therapy: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Embryonic Stem Cell Therapy
  • 7.2.1 Overview
  • 7.2.2 Embryonic Stem Cell Therapy: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Induced Pluripotent Stem Cell Therapy
  • 7.3.1 Overview
  • 7.3.2 Induced Pluripotent Stem Cell Therapy: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Other Stem Cell Therapy
  • 7.4.1 Overview
  • 7.4.2 Other Stem Cell Therapy: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. South & Central America Stem Cell Therapy Market Analysis – by Treatment

8.1 Allogeneic
  • 8.1.1 Overview
  • 8.1.2 Allogeneic: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Autologous
  • 8.2.1 Overview
  • 8.2.2 Autologous: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. South & Central America Stem Cell Therapy Market Analysis – by Application

9.1 Musculoskeletal
  • 9.1.1 Overview
  • 9.1.2 Musculoskeletal: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Dermatology
  • 9.2.1 Overview
  • 9.2.2 Dermatology: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Cardiology
  • 9.3.1 Overview
  • 9.3.2 Cardiology: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Drug Discovery & Development
  • 9.4.1 Overview
  • 9.4.2 Drug Discovery & Development: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.5 Other Applications
  • 9.5.1 Overview
  • 9.5.2 Other Applications: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. South & Central America Stem Cell Therapy Market Analysis – by End User

10.1 Hospitals & Specialty Clinics
  • 10.1.1 Overview
  • 10.1.2 Hospitals & Specialty Clinics: South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Academic & Research Institutes
  • 10.2.1 Overview
  • 10.2.2 Academic & Research Institutes : South & Central America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. South & Central America Stem Cell Therapy Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America
  • 11.2.1 South & Central America Stem Cell Therapy Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 11.2.1.1 South & Central America Stem Cell Therapy Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 Brazil: South & Central America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.1.1 Brazil: South & Central America Stem Cell Therapy Market Breakdown, by Type
    • 11.2.1.1.2 Brazil: South & Central America Stem Cell Therapy Market Breakdown, by Treatment
    • 11.2.1.1.3 Brazil: South & Central America Stem Cell Therapy Market Breakdown, by Application
    • 11.2.1.1.4 Brazil: South & Central America Stem Cell Therapy Market Breakdown, by End User
  • 11.2.1.2 Argentina: South & Central America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.2.1 Argentina: South & Central America Stem Cell Therapy Market Breakdown, by Type
    • 11.2.1.2.2 Argentina: South & Central America Stem Cell Therapy Market Breakdown, by Treatment
    • 11.2.1.2.3 Argentina: South & Central America Stem Cell Therapy Market Breakdown, by Application
    • 11.2.1.2.4 Argentina: South & Central America Stem Cell Therapy Market Breakdown, by End User
  • 11.2.1.3 Rest of South and Central America : South & Central America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.3.1 Rest of South and Central America : South & Central America Stem Cell Therapy Market Breakdown, by Type
    • 11.2.1.3.2 Rest of South and Central America : South & Central America Stem Cell Therapy Market Breakdown, by Treatment
    • 11.2.1.3.3 Rest of South and Central America : South & Central America Stem Cell Therapy Market Breakdown, by Application
    • 11.2.1.3.4 Rest of South and Central America : South & Central America Stem Cell Therapy Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Lonza Group AG
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 Pluri Inc
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Smith & Nephew Plc
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 TiGenix NV (Takeda Pharmaceutical Company Limited)
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - South & Central America Stem Cell Therapy Market

  • Lonza Group AG
  • Pluri Inc
  • Smith & Nephew Plc
  • TiGenix NV (Takeda Pharmaceutical Company Limited)
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)